0001127602-13-002179.txt : 20130117 0001127602-13-002179.hdr.sgml : 20130117 20130117164439 ACCESSION NUMBER: 0001127602-13-002179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130115 FILED AS OF DATE: 20130117 DATE AS OF CHANGE: 20130117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLACKSON TIMOTHY P CENTRAL INDEX KEY: 0001242992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 13535283 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-01-15 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242992 CLACKSON TIMOTHY P C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 President, R&D, CSO Common Stock 2013-01-15 4 M 0 4766 5.23 A 288037 D Common Stock 2013-01-15 4 M 0 44542 4.49 A 332579 D Common Stock 2013-01-15 4 M 0 8631 7.82 A 341210 D Employee Stock Option (Right to Buy) 5.23 2013-01-15 4 M 0 4766 0 D 2006-09-09 2014-09-09 Common Stock 4766 0 D Employee Stock Option (Right to Buy) 4.49 2013-01-15 4 M 0 44542 0 D 2008-04-16 2017-04-16 Common Stock 44542 0 D Employee Stock Option (Right to Buy) 7.82 2013-01-15 4 M 0 8631 0 D 2012-04-01 2021-04-01 Common Stock 8631 17262 D Shares were aquired upon the exercise of outstanding stock options at $5.23 per share. Shares were aquired upon the exercise of outstanding stock options at $4.49 per share. Shares were aquired upon the exercise of outstanding stock options at $7.82 per share. /s/Edward M. Fitzgerald, Attorney-in-Fact 2013-01-17